Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells

被引:25
作者
Sheriff, S
Dautzenberg, FM
Mulchahey, JJ
Pisarka, M
Hauger, RL
Chance, WT
Balasubramanian, A
Kasckow, JW
机构
[1] Vet Adm Med Ctr, Psychiat Serv 116A, Cincinnati, OH 45220 USA
[2] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA
[3] Axovan LTD, Innovat Ctr, CH-4123 Allschwil, Switzerland
[4] Univ Cincinnati, Sch Med, Dept Psychiat, Cincinnati, OH 45267 USA
[5] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92092 USA
[6] VA Med Ctr, La Jolla, CA 92092 USA
[7] Univ Cincinnati, Program Neurosci, Cincinnati, OH 45267 USA
关键词
amygdala; corticotropin-releasing factor; neuropeptide Y; cAMP;
D O I
10.1016/S0196-9781(01)00549-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Corticotropin-releasing factor (CRF) is a 41 amino acid neuropeptide which is involved in the stress response. CRF and neuropeptide Y (NPY) produce reciprocal effects on anxiety in the central nucleus of the amygdala. The molecular mechanisms of possible CRF-NPY interactions in regulating anxiety behavior is not known. In the central nervous system, the action of NPY leads to inhibition of cAMP production while CRF is known to stimulate levels of cAMP in the brain. Consequently, we hypothesized that NPY may antagonize anxiety-like behavior by counter-regulating CRF-stimulated cAMP accumulation and activation of the protein kinase A pathway. We have engineered an immortalized amygdalar cell line (AR-5 cells) which express via RT-PCR, the CRF2alpha, Y-1 and Y5NPY receptor. In addition, in these cells CRF treatment results in significant concentration-dependent increases in cAMP production. Furthermore, incubation of 3 muM CRF with increasing concentrations of NPY was able to significantly inhibit the increases in cAMP compared to that observed with 3 muM CRF treatment alone. These findings suggest that CRF and NPY may counter-regulate each other in amygdalar neurons via reciprocal effects on the protein kinase A pathway. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2083 / 2089
页数:7
相关论文
共 44 条
[1]   EFFECT OF CENTRALLY ADMINISTERED NEUROPEPTIDE-Y ON HYPOTHALAMIC AND HYPOPHYSEAL PROOPIOMELANOCORTIN-DERIVED PEPTIDES IN THE RAT [J].
BLASQUEZ, C ;
JEGOU, S ;
FRIARD, O ;
TONON, MC ;
FOURNIER, A ;
VAUDRY, H .
NEUROSCIENCE, 1995, 68 (01) :221-227
[2]   Y-receptor subtypes - How many more? [J].
Blomqvist, AG ;
Herzog, H .
TRENDS IN NEUROSCIENCES, 1997, 20 (07) :294-298
[3]   Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze [J].
Britton, KT ;
Akwa, Y ;
Spina, MG ;
Koob, GF .
PEPTIDES, 2000, 21 (01) :37-44
[4]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971
[5]   The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons [J].
Dallman, MF ;
Akana, SF ;
Strack, AM ;
Hanson, ES ;
Sebastian, RJ .
STRESS: BASIC MECHANISMS AND CLINICAL IMPLICATIONS, 1995, 771 :730-742
[6]  
DAVIS M, 1992, P255
[7]  
Ehlers C L, 1997, Depress Anxiety, V6, P1
[8]   CHARACTERIZATION AND REGULATION OF BETA-1-ADRENERGIC RECEPTORS IN A HUMAN NEUROEPITHELIOMA CELL-LINE [J].
FISHMAN, PH ;
NUSSBAUM, E ;
DUMAN, RS .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (02) :596-602
[9]  
GAO W, 1995, DEVELOPMENT, V10, P1059
[10]   A receptor subtype involved in neuropeptide-Y-induced food intake [J].
Gerald, C ;
Walker, MW ;
Criscione, L ;
Gustafson, EL ;
BatzlHartmann, C ;
Smith, KE ;
Vaysse, P ;
Durkin, MM ;
Laz, TM ;
Linemeyer, DL ;
Schaffhauser, AO ;
Whitebread, S ;
Hofbauer, KG ;
Taber, RI ;
Branchek, TA ;
Weinshank, RL .
NATURE, 1996, 382 (6587) :168-171